Sph5030

Other Medications

EU Not submitted to EMA ES Not available 2 Clinical Trials

Description

Descripción clínica en INGLÉS: indicaciones en CCR, eficacia general, contexto de uso (3-4 frases)

Mechanism of Action

Mecanismo de acción detallado en INGLÉS (2-3 frases, técnico pero claro)

Side Effects

Efectos secundarios principales en INGLÉS separados por punto y coma

Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.

Clinical Trials

NCT06434597 Phase 2
Recruiting
A Clinical Study of SPH5030 Tablets in the Treatment of Her2-positive/Mutated Biliary Tract OR Colorectal Cancer Patients.
China
NCT05245058 Early Phase 1
Recruiting
SPH5030 Tablets in Subjects With Advanced Her2-positive Solid Tumors
China

Quick Info

CategoryOther Medications
EU EMA StatusNot submitted to EMA
ES Spain AccessNot available
Clinical Trials2
View Clinical Trials Back to Drug Glossary

Related Medications

Uracil
Other Medications
785 trials
Leucovorin
Other Medications
646 trials
Paclitaxel
Other Medications
54 trials
Trifluridine
Other Medications
50 trials
Cyclophosphamid
Other Medications
50 trials
Cyclophosphamide
Other Medications
49 trials

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.